Michael P. Balogh

Michael P. Balogh

Michael P. Balogh is the former editor of "MS - The Practical Art," he wrote his last column in September 2011. He is currently Principal Scientist, LC-MS Technology Development, with Waters Corp., Milford, Massachusetts, and is a member of LCGC's editorial advisory board. Kate Yu has taken over the column. For current articles on the field of mass spectrometry and the various hyphenated techniques, including LC–MS, GC–MS, and tandem MS, please visit: http://www.chromatographyonline.com/Column%3A+MS+-+The+Practical+Art

Articles by Michael P. Balogh

i4-592893-1408673960905.jpg

"...We will restore science to its rightful place, and wield technology's wonders to raise healthcare's quality and lower its cost. We will harness the sun and the winds and the soil to fuel our cars and run our factories...." - President Barack Obama, 44th President of the US, Inaugural address, 20 January 2009, Washington, DC.

i4-572714-1408670304616.gif

Technological changes affecting how we access information - both in the depth of knowledge we can access and the speed - leads to some observations about electronic versus print media. First, anything committed to public view must be of high scholarly order, often serving as a prime resource for equations and things we can't or won't remember. Second, once words have been printed, the value of the meaning they impart decreases as new understanding takes shape.

Two decades ago, MS was the preserve of experts and skilled technicians as the instrumentation required constant attention and adjustment. At that time, liquid chromatography (LC)–MS was in its infancy and atmospheric pressure ionization (API) source interfacing was just beginning. Samples requiring analysis were passed from the requesting scientist to these "experts for analysis." The samples would be analyzed, processed, and interpreted, and the results returned via a written report. Two decades later, the users and capabilities of LC–MS have changed significantly. Now mass spectrometers and LC–MS systems are ubiquitous in the analytical laboratory, especially in the pharmaceutical industry. These instruments are used by a wide variety of scientists for a diverse range of tasks, from purity screening in medicinal chemistry, to the quantification of drugs in blood and the identification of proteins for biomarker discovery. The usability of the current MS platforms has improved..

Michael Balogh begins a three-part overview series, answering questions about mass spectrometers, their use and capabilities, and including links to more detailed further reading in readily available articles written for the nonspecialist.

i1_t-528558-1408664944290.gif

A decade or two ago, the primary users of mass spectrometers were probably graduates of doctoral programmes specializing in mass spectrometry (MS). But as the science evolved and merged with the analytical mainstream, manufacturers redoubled their efforts to make their instruments and operating software user-friendly. These days, specialists in various disciplines use MS as an analytical tool, a development that demands that instrument and software engineers pay close attention to ease-of-use issues and better understand how - and for what purposes - their instruments are used.

Recent work suggests that the practical value of hyphenated techniques is limited by difficulties inherent in achieving definitive compositional answers in general MS. This article argues that it is not impossible in certain cases.

Latest Updated Articles